VictoryShares International High Div Volatility Wtd ETF
Limited financial coverage for CID.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
This fund aims to fulfill its investment goal by typically committing at least 80% of its capital, either directly or indirectly, to the components of the Nasdaq Victory International High Dividend 100 Volatility Weighted Index. This particular benchmark is passively managed, employs a volatility-weighted methodology, and is exclusively overseen by its designated index provider. Its selection criteria involve identifying the 100 international stocks with the highest dividend payouts from the broader Nasdaq Victory International 500 Volatility Weighted Index.
- IPO
- 2015
- HQ
- San Antonio, TX, US
Get TickerSpark's AI analysis on CID
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $17.04M
- Div Yield
- 5.30%
- 52W High
- $34.35
- 52W Low
- $30.41
- 50D MA
- $33.49
- 200D MA
- $32.51
- Beta
- 0.91
- RSI (14)
- 42
- Avg Volume
- 5.71K
No earnings-call transcripts are available for CID yet.
- Free Float
- 0.0%
- Shares Outstanding
- 516.09K
- Float Shares
- 0
of shares held by institutions
12 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Ladenburg Thalmann Financial Services Inc. | 28.21K | ▼ 90 |
| Advisor Group, Inc. | 3.26K | ▼ 23.96K |
Our CID coverage
Recent articles, reports, and earnings notes.
No research on CID yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CID report →Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
accessnewswire.com · Jun 23
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
accessnewswire.com · Apr 8
Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
accessnewswire.com · Jan 2
CID HoldCo, Inc. Provides Market Update and Clarifies Recent Trading Activity
businesswire.com · Dec 30
Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
accessnewswire.com · Sep 25
83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey
accessnewswire.com · Mar 28
The EU's Clean Industrial Deal Can't Succeed Without Using a Major Leap in Technology
accessnewswire.com · Mar 3
CID Boss Maj Magambo Warns: System Will Come For Anyone Planning Chaos in Upcoming Elections
watchdoguganda.com · Sep 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.